-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Revenues history and growth rate from Q1 2011 to Q3 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Revenues for the quarter ending September 30, 2024 was $272K, a 63.3% decline year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Revenues for the twelve months ending September 30, 2024 was $3.45M, a 76.9% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Revenues for 2024 was $3.45M, a 76.9% increase from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Revenues for 2023 was $1.95M, a 1041% increase from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Revenues for 2022 was $171K, a 3.92% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)